No Detail Found!

Comparison of montelukast and ketotifen sodium in management of childhood asthma

Author(s)
Sadaf Nawaz Departments of Pediatrics, Rai Medical College, Sargodha, Poonch Medical College, Rawal Institute of Health Sciences, Islamabad and Combined Military Hospital,Muzaffarabad,Pakistan
Raja Imtiaz Ahmed Departments of Pediatrics, Rai Medical College, Sargodha, Poonch Medical College, Rawal Institute of Health Sciences, Islamabad and Combined Military Hospital,Muzaffarabad,Pakistan
Kamran Arzoo Departments of Pediatrics, Rai Medical College, Sargodha, Poonch Medical College, Rawal Institute of Health Sciences, Islamabad and Combined Military Hospital,Muzaffarabad,Pakistan
Irum Javed Departments of Pediatrics, Rai Medical College, Sargodha, Poonch Medical College, Rawal Institute of Health Sciences, Islamabad and Combined Military Hospital,Muzaffarabad,Pakistan
Nasim Ilyas Departments of Pediatrics, Rai Medical College, Sargodha, Poonch Medical College, Rawal Institute of Health Sciences, Islamabad and Combined Military Hospital,Muzaffarabad,Pakistan
Kashif Rahim Departments of Pediatrics, Rai Medical College, Sargodha, Poonch Medical College, Rawal Institute of Health Sciences, Islamabad and Combined Military Hospital,Muzaffarabad,Pakistan
Abstract
Objective: To compare montelukast and ketotifen sodium in management of childhood asthma in Muzzafrabad, Pakistan. Methodology: This randomized controlled trial of 6months duration from 15th May to 30th November 2017 was carried out at Pediatrics department of combined military hospital Muzaffarabad. It included 60 cases and were randomly divided into 2 groups; Group A was given Ketotifen 1mg once a day orally and Group B was given Montelukast sodium 5mg once a day orally at nighttime. Outcome was determined at 3rd month after treatment in terms of recurrence of severity of asthma using asthma severity score. Results: Mean age was 8.58±3.27 years in all cases, while mean age in group-A and group-B was 8.93±3.18 years and 8.23±3.37 years. Overall, there were 36(60%) male and 24(40%) female cases while in group-A there were 22(73.3%) male and 8(26.7%) female cases and in group-B there were 14(46.7%) male and 16(53.3%) female cases. Mean severity in both groups before treatment was same (p=0.111). Mean Asthma severity score before treatment in group-A and group-B was 11.37±2.57 and 10.10±3.44, respectively. Mean Asthma score after treatment in group-A was higher (3.60±1.25) than group-B (2.10±0.92) (p<0.001). Conclusion: Montelukast sodium 5mg once a day orally at night time was more effective to reduce the severity of asthma at even at 3rd month of treatment as compared to Ketotifen 1mg once a day orally. By utilizing the therapeutic efficacy of Montelukast sodium 5mg we can overcome the severity of bronchial asthma and can improve patient's quality of life. 
Publication Details
Page(s) 500-502
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 46, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
asthma, Montelukast, ketotifen
0

Citations

0

Downloads

59

Views